TransMedics Group, Inc. (TMDX)
Automate Your Wheel Strategy on TMDX
With Tiblio's Option Bot, you can configure your own wheel strategy including TMDX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol TMDX
- Rev/Share 16.6026
- Book/Share 10.4126
- PB 13.0034
- Debt/Equity 1.4621
- CurrentRatio 7.6893
- ROIC 0.1084
- MktCap 4627169431.0
- FreeCF/Share 3.5367
- PFCF 38.353
- PE 50.3328
- Debt/Assets 0.549
- DivYield 0
- ROE 0.3142
- Rating B-
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | TMDX | Needham | Hold | Buy | -- | $148 | Oct. 23, 2025 |
| Initiation | TMDX | Jefferies | -- | Buy | -- | $145 | Oct. 13, 2025 |
| Initiation | TMDX | Evercore ISI | -- | Outperform | -- | $155 | Sept. 16, 2025 |
| Initiation | TMDX | Stifel | -- | Hold | -- | $115 | Sept. 4, 2025 |
| Downgrade | TMDX | JP Morgan | Overweight | Neutral | $116 | $75 | Dec. 17, 2024 |
| Initiation | TMDX | Robert W. Baird | -- | Outperform | -- | $200 | Sept. 24, 2024 |
| Initiation | TMDX | Needham | -- | Buy | -- | $208 | Aug. 21, 2024 |
News
TMDX INVESTOR REPORT: TransMedics Group, Inc. is being Investigated for Securities Fraud - Contact BFA Law if you Suffered Losses
Published: February 10, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / February 10, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into TransMedics Group, Inc. (NASDAQ:TMDX) for potential violations of the federal securities laws. If you invested in TransMedics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/transmedics-group-inc.
Read More
TransMedics Group (TMDX) Plunges Amidst Allegations of Fraud, Organ Trafficking – Hagens Berman
Published: February 10, 2025 by: GlobeNewsWire
Sentiment: Neutral
SAN FRANCISCO, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Shares of TransMedics, Group Inc. (NASDAQ: TMDX) suffered a sharp decline over the past two trading days following the release of a damaging report by activist short-seller Scorpion Capital. TransMedics' stock price has dropped $9.84, or 13%, since Scorpion released a report, titled “Walk Like An Egyptian,” leveling serious allegations against the company, including fraud, organ trafficking, and off-label device misuse.
Read More
The Schall Law Firm Invites Investors With Losses In TransMedics Group, Inc. To Join A Securities Fraud Investigation
Published: February 10, 2025 by: Accesswire
Sentiment: Neutral
LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of TransMedics Group, Inc. ("TransMedics" or "the Company") (NASDAQ:TMDX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Read More
About TransMedics Group, Inc. (TMDX)
- IPO Date 2019-05-02
- Website https://www.transmedics.com
- Industry Medical - Devices
- CEO Waleed H. Hassanein
- Employees 728